Skip to main content
Veterinary Medicines

CYDECTIN TRICLAMOX 1 MG/ML + 50 MG/ML ORAL SOLUTION FOR SHEEP

Authorised
  • Triclabendazole
  • Moxidectin

Product identification

Medicine name:
CYDECTIN TRICLAMOX 1 MG/ML + 50 MG/ML ORAL SOLUTION FOR SHEEP
CYDECTINE TRICLAMOX 1 MG/ML + 50 MG/ML SOLUTION BUVABLE POUR OVINS
Active substance:
  • Triclabendazole
  • Moxidectin
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Moxidectin
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        31
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB52
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0822223 7/2009
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0201/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023

Combined File of all Documents

English (PDF)
Published on: 19/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."